| scholarly article | Q13442814 |
| P50 | author | Harvey M. Friedman | Q89912954 |
| P2093 | author name string | David A Leib | |
| Sita Awasthi | |||
| Jesse Mehrbach | |||
| Sean A Taylor | |||
| Chaya D Patel | |||
| P2860 | cites work | Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections | Q22305966 |
| Maternal and neonatal herpes simplex virus infections | Q24653520 | ||
| Microbial Vertical Transmission during Human Pregnancy | Q29994499 | ||
| Localization of herpes simplex virus type 1 UL37 in the Golgi complex requires UL36 but not capsid structures | Q30439761 | ||
| Relationship of antibody to outcome in neonatal herpes simplex virus infections | Q33906594 | ||
| Current status and prospects for development of an HSV vaccine | Q33931016 | ||
| Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes | Q34057952 | ||
| Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant | Q34169094 | ||
| Mother-to-Child Transmission of Herpes Simplex Virus | Q34181697 | ||
| The acquisition of herpes simplex virus during pregnancy | Q34436031 | ||
| Influenza vaccination of pregnant women and protection of their infants | Q34436687 | ||
| An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. | Q34549656 | ||
| The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo | Q34742635 | ||
| Transplacental transfer and subsequent neonate utilization of herpes simplex virus-specific immunity are resilient to acute maternal stress | Q35020459 | ||
| Herpes simplex virus infections of women and their offspring: implications for a developed society | Q35114519 | ||
| Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice | Q35162205 | ||
| Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection | Q35236237 | ||
| Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa | Q35275146 | ||
| Neonatal herpes simplex infection | Q35545367 | ||
| Efficacy results of a trial of a herpes simplex vaccine | Q35780697 | ||
| Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. | Q35824550 | ||
| Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus | Q35833656 | ||
| Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. | Q45819868 | ||
| Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells | Q45823697 | ||
| Humoral and cell-mediated immunity in neonates with herpes simplex virus infection | Q45835586 | ||
| Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus | Q45838593 | ||
| Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes | Q45842204 | ||
| Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group | Q45853297 | ||
| A Human Open Field Test Reveals Thigmotaxis Related to Agoraphobic Fear | Q46595987 | ||
| Update on Neonatal Herpes Simplex Epidemiology in the Netherlands: A Health Problem of Increasing Concern? | Q47546244 | ||
| Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections | Q47546281 | ||
| Varicella and herpes zoster vaccine development: lessons learned | Q47607699 | ||
| Preventing neonatal herpes infections through maternal immunization | Q47728707 | ||
| Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions | Q48153919 | ||
| An elevated plus-maze in mixed reality for studying human anxiety-related behavior | Q48363331 | ||
| Acute and chronic neurological consequences of early-life Zika virus infection in mice. | Q55084399 | ||
| Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs. | Q55406946 | ||
| Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection | Q55982678 | ||
| The Impact of IgG transplacental transfer on early life immunity | Q56505186 | ||
| Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes | Q57076537 | ||
| Seroprevalence of Herpes Simplex Virus Types 1 and 2 Among Pregnant Women and Sexually Active, Nonpregnant Women in the United States | Q59349344 | ||
| General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q64129678 | ||
| Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity | Q66680679 | ||
| Herpesvirus infections in pregnancy: a comparison of neutralizing antibody titers in mothers and their infants | Q68684053 | ||
| Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes | Q90196797 | ||
| Inconsistent Management of Neonatal Herpes Simplex Virus Infections | Q90388660 | ||
| A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection | Q90520696 | ||
| Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2 | Q90627411 | ||
| A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection | Q91784909 | ||
| Maternal Immunization | Q92627465 | ||
| Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009-2015 | Q92686264 | ||
| Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry | Q35890209 | ||
| Neonatal Herpes Simplex Virus Type 1 Infection and Jewish Ritual Circumcision With Oral Suction: A Systematic Review. | Q36170180 | ||
| Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus | Q36461188 | ||
| Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection | Q36461193 | ||
| Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding | Q36630996 | ||
| The challenge of developing a herpes simplex virus 2 vaccine | Q36671106 | ||
| The use of the elevated plus maze as an assay of anxiety-related behavior in rodents | Q36759180 | ||
| A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. | Q36831366 | ||
| Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system | Q36974311 | ||
| Efficacy of varicella (VZV) vaccination: an update for the clinician | Q37158220 | ||
| Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection | Q37357122 | ||
| An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1. | Q37561211 | ||
| Correlate of immune protection against HSV-1 genital disease in vaccinated women | Q37604473 | ||
| Pertussis and influenza immunisation during pregnancy: a landscape review | Q38691984 | ||
| Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease. | Q38692329 | ||
| First estimates of the global and regional incidence of neonatal herpes infection. | Q38762673 | ||
| Treatment of perinatal viral infections to improve neurologic outcomes | Q38965659 | ||
| Maternal immunisation: collaborating with mother nature | Q39256585 | ||
| Postnatal acquisition of herpes simplex virus by the newborn infant: a review of the literature | Q39908056 | ||
| The Role of Herpes Simplex Virus Type 1 γ34.5 in the Regulation of IRF3 Signaling | Q40042444 | ||
| A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model | Q40210971 | ||
| Prevalence of herpes simplex virus types 1 and 2 at maternal and fetal sides of the placenta in asymptomatic pregnant women | Q40228967 | ||
| Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial | Q40280300 | ||
| Herpes simplex virus infection in young infants during 2 decades of empiric acyclovir therapy | Q40334643 | ||
| Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? | Q40695679 | ||
| Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization | Q41726663 | ||
| An open-source toolbox for automated phenotyping of mice in behavioral tasks | Q42236246 | ||
| In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts | Q42508580 | ||
| Immunology. Painful failure of promising genital herpes vaccine | Q43721308 | ||
| Prenatal transfer of low amounts of herpes simplex virus (HSV)-specific antibody protects newborn mice against HSV infection during acute maternal stress | Q44001047 | ||
| Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection | Q44851633 | ||
| Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. | Q45257878 | ||
| Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017. | Q45323563 | ||
| A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease | Q45324468 | ||
| A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus | Q45325844 | ||
| Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine | Q45353080 | ||
| Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission | Q45391170 | ||
| Maternal herpes simplex virus antibody avidity and risk of neonatal herpes | Q45415002 | ||
| Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge | Q45732455 | ||
| Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial | Q45759646 | ||
| Mechanism of complement inactivation by glycoprotein C of herpes simplex virus | Q45764786 | ||
| The natural history of herpes simplex virus infection of mother and newborn | Q45802995 | ||
| P921 | main subject | Neonatal herpes simplex | Q3134326 |
| P577 | publication date | 2020-03-18 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity |
| Q100517411 | Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine | cites work | P2860 |
Search more.